📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
301 analysed today
FollowTelegram
301
Today
149,702
All-time analysed
42,924
Positive
6,662
Negative
91,435
Neutral
8,613
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1,000+ announcements match the current filters (relevance ≥ 5).
Continental Controls to Finalize Terms for Up to ₹50 Cr Rights Issue on Oct 8, 2026
Continental Controls has scheduled a Rights Issue Committee meeting on October 08, 2026, to finalize the issue price, entitlement ratio, record date, and issue dates. The rights issue proposal is for an aggregate amount of up to ₹50 Crores, involving equity shares with a face value of ₹10 each. This planned fundraise is massive relative to the company's current scale, exceeding its ₹9 Crore market capitalization by more than 5x and its current net worth of ₹2 Crores by 25x.
Confidence: HIGH
What changedThe company has scheduled a committee meeting to determine the final pricing and timeline for its previously approved rights issue.
Why it mattersA ₹50 Crore equity raise relative to a ₹9 Crore market cap and ₹2 Crore net worth implies massive equity dilution and potential balance sheet transformation.
Proposed Rights Issue Size: up to Rs. 50 CroresFace Value per Share: Rs. 10/-Meeting Date: October 08, 2026Issue Size vs Market Cap: ~555%
📅 Short termShare price volatility is likely around the announcement of the rights issue price, entitlement ratio, and record date on October 8.
📈 Long termIf successfully executed, the capital influx could fund business expansion, but existing shareholders face extreme dilution if they do not participate.
⚠ Risk flags
- Severe equity dilution risk due to the size of the issue relative to existing market cap
- Low historical promoter holding of 24.56%
- Execution and capital deployment risk for a micro-cap company raising >5x its market cap
Key Highlights
Rights Issue Committee meeting scheduled for Thursday, October 08, 2026
Committee to decide Issue Price, Entitlement Ratio, Record date, and Issue dates
Proposed rights issue size aggregates up to ₹50 Crores of face value ₹10 equity shares
Fundraise represents ~5.55x the current market capitalization of ₹9 Crores
👀 What to Watch
Track the outcome of the October 08, 2026 committee meeting to note the issue price, dilution ratio, and record date.
DP Abhushan Approves ₹558 Cr Preferential Issue of Shares and Warrants at ₹1,430/Share
The Board of D. P. Abhushan Limited approved a preferential allotment to raise up to ₹558.01 crore via equity shares and convertible warrants at an issue price of ₹1,430 per unit. The raise comprises 8,66,434 equity shares worth ₹123.90 crore and 30,35,711 convertible warrants totaling ₹434.11 crore. Key warrant subscribers include marquee investor Mukul Mahavir Agrawal (₹100.03 crore) and Motilal Oswal Financial Services (₹75 crore). Post-conversion, promoter shareholding will dilute from 74.89% to 66.46%, representing an equity dilution of approximately 14.8% on the expanded capital base.
Confidence: HIGH
What changedThe Board approved a major capital raise of ₹558.01 crore via preferential shares and warrants at ₹1,430 per share/warrant to institutional and strategic investors.
Why it mattersThe fundraise represents ~7.4% of market cap and ~88% of net worth, providing substantial growth capital to fund retail footprint expansion while bringing marquee institutional investors onto the cap table.
Total fundraise value: ₹558.01 croreIssue price per share/warrant: ₹1,430.00Fundraise vs Net Worth: ~88.1%Fundraise vs Market Cap: ~7.4%Post-issue promoter holding: 66.46%
📅 Short termApproval at the upcoming EGM and receipt of the initial warrant subscription money (25%) will be the immediate milestones to track over the next few weeks.
📈 Long termThe infusion significantly strengthens the balance sheet, helping the company expand into western Indian states (Gujarat, Maharashtra) and lower financial leverage.
⚠ Risk flags
- Equity dilution of ~14.8% on fully converted equity base
- Issue price of ₹1,430 is at a discount to the prevailing market price of ₹2,130.50
Key Highlights
Board approved ₹123.90 crore via 8,66,434 equity shares at ₹1,430 per share
Board approved ₹434.11 crore via 30,35,711 warrants convertible within 18 months at ₹1,430 per warrant
Total combined capital raise stands at ₹558.01 crore, equivalent to ~88% of net worth (₹633 crore)
Promoter holding to decline from 74.89% to 66.46% post full conversion of warrants
Notable allottees include Mukul Agrawal (6,99,500 warrants) and Motilal Oswal (5,24,450 warrants)
👀 What to Watch
Track the upcoming Extraordinary General Meeting (EGM) for shareholder approval and watch for subsequent disclosures outlining specific fund utilization for store network expansion.
Royal Cushion Vinyl Allots 41.17 Lakh Equity & 84.99 Lakh NCRPS Shares Under Amalgamation Scheme
Royal Cushion Vinyl Products has approved the allotment of 41,17,160 equity shares of Rs 10 each and 84,99,592 non-convertible redeemable preference shares (NCRPS) of Rs 10 each pursuant to the amalgamation of Royal Spinwell and Developers Private Limited. The allotment increases the company's paid-up equity share capital from Rs 36.59 crore to Rs 40.71 crore, causing an equity dilution of ~10.1%. In addition, the unlisted 6% NCRPS add Rs 8.50 crore of preference share capital redeemable within up to 20 years. The amalgamation scheme became effective August 30, 2026, following NCLT approval on July 28, 2026.
Confidence: HIGH
What changedThe Board approved the issuance of 41.17 lakh equity shares and 84.99 lakh 6% NCRPS to execute the merger of Royal Spinwell and Developers Private Limited.
Why it mattersThe issuance expands the paid-up equity base by 11.25% (dilution of 10.1%) and adds an Rs 8.5 crore 6% dividend preference obligation for a company currently operating with negative net worth (-Rs 37 Cr) and trailing net losses.
Equity shares allotted: 41,17,160NCRPS shares allotted: 84,99,592New paid-up equity capital: Rs. 40,70,56,220Added preference capital: Rs. 8,49,95,920Equity dilution: ~10.1%
📅 Short termSubject to BSE trading approval, the new equity shares will be listed, marginally increasing the floating stock.
📈 Long termStructural impact depends on the operational assets or liabilities absorbed from Royal Spinwell and Developers Private Limited into Royal Cushion's strained balance sheet.
⚠ Risk flags
- Equity dilution of ~10.1% on an already loss-making entity
- 6% preferential dividend and eventual redemption liability from Rs 8.50 crore of NCRPS
- Company currently operates with negative net worth (-Rs 37 Cr) and TTM net losses
Key Highlights
Allotment of 41,17,160 equity shares of Rs 10 each at par pursuant to the NCLT-approved merger scheme
Allotment of 84,99,592 unlisted 6% Non-Convertible Redeemable Preference Shares of Rs 10 each (Rs 8.50 crore face value)
Paid-up equity capital increases from Rs 36,58,84,620 to Rs 40,70,56,220 (~10.1% increase in share count)
Amalgamation scheme of Royal Spinwell and Developers Pvt Ltd effective from August 30, 2026
👀 What to Watch
Track listing approval from BSE for the 41.17 lakh newly allotted equity shares and monitor upcoming quarterly filings for any financial assets or debt consolidated from the merged entity.
Transworld Completes Sale of Vessel M.V. SSL Sabarimalai to Avana Logistek
Transworld Shipping Lines Limited announced the successful completion of the sale of its vessel, M.V. SSL Sabarimalai, to Avana Logistek Limited on October 5, 2026. The transaction concluded with the execution of the Protocol of Delivery and Acceptance, and the vessel was officially delivered at Vishakhapatnam, India. The monetary consideration and financial impact of the sale were not disclosed in this filing. The company had previously operated a fleet of 12 vessels, meaning this disposal marginally alters its operational fleet composition.
Confidence: MEDIUM
What changedTransworld Shipping Lines finalized the sale and transferred physical delivery of M.V. SSL Sabarimalai to Avana Logistek Limited.
Why it mattersThe sale reduces the operating fleet count (previously 12 vessels) and may generate cash proceeds to manage debt (currently at Rs 265 Cr), although financial terms were not shared.
Completion Date: 05th October 2026Delivery Location: Vishakhapatnam, IndiaPrior Fleet Size: 12 vesselsSale Consideration: not disclosed
📅 Short termLimited share price impact expected as the prior intimation was made on August 4, 2026, and exact financial realization figures are absent.
📈 Long termAligns with the company's broader strategic portfolio adjustments and diversification towards dry bulk operations as fleet deployment stabilizes.
⚠ Risk flags
- Financial realization and valuation metrics of the vessel not disclosed
- Related-party transaction dynamics given Avana Logistek is a key client
Key Highlights
Sale of vessel M.V. SSL Sabarimalai completed on October 5, 2026
Delivery executed at Vishakhapatnam, India pursuant to the Protocol of Delivery and Acceptance
Buyer is related party/major customer Avana Logistek Limited
Transaction consideration and gain/loss on sale: not disclosed in the filing
👀 What to Watch
Track the upcoming Q2/Q3 FY27 financial results to identify the sale consideration, any exceptional profit/loss generated from this disposal, and its impact on the remaining fleet size.
Pro Fin Capital Approves ₹92.40 Cr Preferential Warrant Issue and Capital Increase
Pro Fin Capital Services Ltd's board has approved the issuance of up to 33,00,00,000 convertible equity share warrants at ₹2.80 each, aggregating up to ₹92.40 crore on a preferential basis to non-promoter public investors. This proposed fundraise represents approximately 88% of the company's current market capitalization of ₹105 crore and would result in 35.77% post-issue dilution upon full conversion. The board also approved an increase in authorized share capital from ₹65 crore to ₹94 crore to accommodate the issuance. The warrants are convertible into equity shares within 18 months, subject to shareholder approval at an upcoming Extraordinary General Meeting (EGM).
Confidence: HIGH
What changedBoard approved raising up to ₹92.40 crore via 33 crore convertible warrants and increased authorized share capital to ₹94 crore.
Why it mattersA massive capital infusion representing ~88% of market capitalization will inject substantial cash to support operations or pay down ₹281 crore in debt, but will also lead to significant equity dilution (~35.77%).
Total Issue Size: Rs. 92,40,00,000Issue Price per Warrant: Rs. 2.80Number of Warrants: 33,00,00,000Issue Size vs Market Cap: ~88%Post-issue Stake of Allottees: 35.77%
📅 Short termMarket focus will shift to shareholder approval via EGM and receipt of 25% upfront warrant subscription money upon allotment.
📈 Long termIf fully converted over 18 months, the company's net worth could expand significantly, but existing shareholder value could face heavy dilution unless capital is deployed into high-return avenues.
⚠ Risk flags
- Substantial equity dilution of 35.77% on warrant conversion
- Extremely low promoter holding currently at ~3.9%, which will dilute further
- High existing leverage with debt at ₹281 Cr relative to net worth of ₹68 Cr
Key Highlights
Board approved issuance of up to 33,00,00,000 convertible equity share warrants aggregating to ₹92,40,00,000
Issue price set at ₹2.80 per warrant (face value ₹1 plus premium of ₹1.80)
Authorized share capital increased from ₹65,00,00,000 to ₹94,00,00,000
Post-conversion, proposed allottees will hold a 35.77% stake in the expanded equity capital
Conversion window open within 18 months from allotment date
👀 What to Watch
Track shareholder voting results at the upcoming EGM and monitor subsequent regulatory approvals and warrant subscription details.
Pro Fin Capital Approves ₹92.40 Cr Preferential Warrant Issue and Capital Increase
Pro Fin Capital Services Ltd's board has approved the issuance of up to 33,00,00,000 convertible equity share warrants at ₹2.80 each, aggregating up to ₹92.40 crore on a preferential basis to non-promoter public investors. This proposed fundraise represents approximately 88% of the company's current market capitalization of ₹105 crore and would result in 35.77% post-issue dilution upon full conversion. The board also approved an increase in authorized share capital from ₹65 crore to ₹94 crore to accommodate the issuance. The warrants are convertible into equity shares within 18 months, subject to shareholder approval at an upcoming Extraordinary General Meeting (EGM).
Confidence: HIGH
What changedBoard approved raising up to ₹92.40 crore via 33 crore convertible warrants and increased authorized share capital to ₹94 crore.
Why it mattersA massive capital infusion representing ~88% of market capitalization will inject substantial cash to support operations or pay down ₹281 crore in debt, but will also lead to significant equity dilution (~35.77%).
Total Issue Size: Rs. 92,40,00,000Issue Price per Warrant: Rs. 2.80Number of Warrants: 33,00,00,000Issue Size vs Market Cap: ~88%Post-issue Stake of Allottees: 35.77%
📅 Short termMarket focus will shift to shareholder approval via EGM and receipt of 25% upfront warrant subscription money upon allotment.
📈 Long termIf fully converted over 18 months, the company's net worth could expand significantly, but existing shareholder value could face heavy dilution unless capital is deployed into high-return avenues.
⚠ Risk flags
- Substantial equity dilution of 35.77% on warrant conversion
- Extremely low promoter holding currently at ~3.9%, which will dilute further
- High existing leverage with debt at ₹281 Cr relative to net worth of ₹68 Cr
Key Highlights
Board approved issuance of up to 33,00,00,000 convertible equity share warrants aggregating to ₹92,40,00,000
Issue price set at ₹2.80 per warrant (face value ₹1 plus premium of ₹1.80)
Authorized share capital increased from ₹65,00,00,000 to ₹94,00,00,000
Post-conversion, proposed allottees will hold a 35.77% stake in the expanded equity capital
Conversion window open within 18 months from allotment date
👀 What to Watch
Track shareholder voting results at the upcoming EGM and monitor subsequent regulatory approvals and warrant subscription details.
CRISIL Assigns 'BBB-/Stable' & 'A3' Ratings to Rox Hi-Tech's Rs 125 Cr Bank Facilities
Rox Hi-Tech Limited has received fresh credit ratings from CRISIL Ratings for its bank facilities. The rating agency assigned a long-term rating of 'CRISIL BBB-/Stable' for Rs 125 Crores of bank facilities and a short-term rating of 'CRISIL A3'. The rated facilities of Rs 125 Crores compare against the company's existing debt of Rs 69 Crores and net worth of Rs 132 Crores, reflecting adequate coverage for its ongoing operational growth and working capital needs.
Confidence: HIGH
What changedCRISIL assigned new credit ratings of 'CRISIL BBB-/Stable' (long term) and 'CRISIL A3' (short term) to Rox Hi-Tech's bank facilities.
Why it mattersSecuring an investment-grade rating allows the company to formalize and access up to Rs 125 Crores in bank funding to support working capital and its pipeline execution.
Rated Long Term Bank Facilities: Rs. 125 CroresLong Term Rating: Crisil BBB-/ stableShort Term Rating: Crisil A3Facilities vs Net Worth: ~94.7%
📅 Short termValidates credit standing with lenders; provides bank headroom for ongoing contracts.
📈 Long termSupports financial flexibility and lower borrowing costs as the company scales operations and executes its order pipeline.
⚠ Risk flags
- BBB- is the lowest tier of investment grade, making future downgrades a risk if leverage increases materially.
Key Highlights
CRISIL assigned 'CRISIL BBB-/Stable' rating for Long Term Bank facilities
Assigned 'CRISIL A3' rating for Short Term bank facilities
Total rated Long Term Bank facilities stand at Rs 125 Crores
Rated facilities of Rs 125 Crores compare to existing debt of Rs 69 Crores and net worth of Rs 132 Crores
👀 What to Watch
Track whether the assigned investment-grade ratings help lower the company's borrowing costs and monitor future quarterly debt levels against the Rs 125 Cr facility.
NCLT Directs Kothari Sugars to Convene Shareholder Meeting on Nov 13 for Merger with KPL
Kothari Sugars and Chemicals Limited (KSCL) has received an order from the NCLT Chennai Bench directing it to convene meetings of equity shareholders and unsecured creditors on November 13, 2026. This pertains to the proposed Scheme of Amalgamation to merge KSCL into Kothari Petrochemicals Limited (KPL). Indian Bank, the secured creditor for both entities, has already provided consent, leading NCLT to dispense with secured creditor meetings. KSCL generated TTM revenue of ₹247 Cr and had a market cap of ₹213 Cr prior to this step.
Confidence: HIGH
What changedNCLT Chennai has formally allowed the joint First Motion Application, ordering shareholder and creditor voting on November 13, 2026.
Why it mattersThe merger will lead to the dissolution of KSCL as an independent entity and integrate its operations with Kothari Petrochemicals.
Meeting date: November 13, 2026NCLT order date: September 30, 2026KSCL Market Cap: ₹213 CrKSCL TTM Revenue: ₹247 Cr
📅 Short termShareholder attention will shift to voting notices, proxy forms, and valuation/swap ratio details ahead of the November 13, 2026 meeting.
📈 Long termIf approved by shareholders and finally sanctioned by NCLT, KSCL will be absorbed into KPL, altering the consolidated operational and financial profile.
⚠ Risk flags
- Merger remains subject to equity shareholder approval and final NCLT sanction
- Integration execution risks between sugar/distillery and petrochemical operations
Key Highlights
NCLT Chennai Bench pronounced order on September 30, 2026, directing shareholder and creditor meetings
Equity shareholders and unsecured creditors meetings scheduled for Friday, November 13, 2026
Indian Bank consented to the scheme, dispensing with secured creditor meetings for both companies
KSCL (market cap ₹213 Cr) to be amalgamated with and into Kothari Petrochemicals Limited (KPL)
👀 What to Watch
Track voting outcomes of the November 13, 2026 shareholder meeting and monitor the swap ratio details and final NCLT sanction.
AWL Q2 FY27 Update: Standalone Revenue Up 24% YoY, Food & FMCG Crosses ₹2,000 Cr
AWL Agri Business reported preliminary Q2 FY27 standalone metrics featuring 12% YoY overall volume growth and 24% YoY revenue growth. Growth was spearheaded by the Food & FMCG business, which grew 33% YoY to cross ₹2,000 crore in quarterly revenue for the first time. The core Edible Oil segment reported 3% YoY volume growth, while Industry Essentials grew volumes by 25% YoY. The performance reflects steady volume traction across staples alongside portfolio premiumization and rapid scaling in Quick Commerce and E-commerce channels.
Confidence: HIGH
What changedAWL released its Q2 FY27 quarterly business update, showing accelerated top-line momentum with 24% YoY revenue growth compared to past quarters.
Why it mattersDemonstrates rapid scaling in the higher-margin Food & FMCG segment (reaching over ₹2,000 crore quarterly), helping reduce company dependence on the lower-margin edible oil segment.
Overall revenue growth (YoY): 24%Overall volume growth (YoY): 12%Food & FMCG quarterly revenue: crossed ₹2,000 croreFood & FMCG revenue growth (YoY): 33%Industry Essentials volume growth (YoY): 25%Edible Oil volume growth (YoY): 3%
📅 Short termPositive sentiment likely due to strong volume/revenue traction, though margin figures remain pending until full board approval.
📈 Long termFood & FMCG reaching ₹2,000 cr/quarter validates the strategy of diversifying away from commodity-linked edible oils towards higher-margin branded staples.
⚠ Risk flags
- Margin volatility from fluctuations in edible oil import duty differentials and international commodity prices
- Subdued volume growth (3%) in the core Edible Oil segment
Key Highlights
Overall standalone performance delivered 12% YoY volume growth and 24% YoY revenue growth in Q2 FY27
Food & FMCG revenue surged 33% YoY, surpassing ₹2,000 crore in a single quarter for the first time
Edible Oil business posted 3% YoY volume growth, supported by domestic oils like Mustard and Rice Bran
Industry Essentials volumes grew 25% YoY, driven by Oleochemicals, Castor, and De-oiled Cakes
Subsidiary GD Foods (Tops) posted 30%+ YoY revenue growth, while Fortune Pulses crossed ₹100 crore in quarterly revenue
👀 What to Watch
Track the full Q2 FY27 financial results for operating margin impact, particularly following the government's import duty cuts on edible oils implemented on September 23, 2026.
Zydus and MSN Partner to Launch First Generic of Adempas (Riociguat) in the U.S.
Zydus Lifesciences has partnered with MSN Laboratories to launch the first generic equivalent of Adempas (Riociguat Tablets) in the U.S. across all five strengths (0.5 mg to 2.5 mg). Riociguat was previously available only as a branded drug in the U.S., with originator Bayer reporting global Adempas sales of ~EUR 745 million (~USD 850 million) in 2025. The product is manufactured and developed by MSN, while Zydus leverages its U.S. commercial platform for distribution. This first-to-market advantage gives Zydus a significant near-term specialty generics opportunity relative to its TTM revenue of ₹27,148 crore.
Confidence: HIGH
What changedZydus and MSN have launched the first generic version of Bayer's Adempas in the United States.
Why it mattersBeing first-to-market provides competitive pricing power and limited competition initially in a high-value niche market that recorded ~$850 million globally in 2025.
Innovator global sales (2025): EUR 745 million (~USD 850 million)Dosage strengths launched: 5 (0.5 mg, 1 mg, 1.5 mg, 2 mg, 2.5 mg)Zydus TTM revenue context: ₹27,148 Cr
📅 Short termPositive sentiment driver as day-one generic launches in the U.S. typically generate strong margins during the exclusivity or limited-competition window.
📈 Long termBolsters Zydus' specialty and complex generics portfolio in the U.S., though exclusivity will eventually erode as subsequent generic competitors enter.
⚠ Risk flags
- Commercial terms and profit-sharing ratio between Zydus and MSN are not disclosed
- Potential competition from other generic entrants over time causing price erosion
Key Highlights
First generic launch of Adempas (riociguat tablets) in the U.S. market across all 5 strengths (0.5 mg, 1 mg, 1.5 mg, 2 mg, and 2.5 mg)
Global sales of branded Adempas reported at ~EUR 745 million (~USD 850 million) in 2025 by innovator Bayer
Product developed and manufactured by MSN Laboratories and commercialized by Zydus in the U.S.
Indicated for chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
👀 What to Watch
Track initial market share capture and pricing dynamics in subsequent quarterly reports (starting Q3 FY27) to assess the revenue contribution and commercial margin-split terms with MSN.
Anawil Reports ₹359.82 Cr Order Book Plus ₹133.98 Cr Win; Capacity Reaches 612 Towers
Anawil Wire and Engineering detailed key operational updates following its investor conference. As of March 31, 2026, the company's order book stood at ~₹359.82 crore (379 towers across six clients), subsequent to which it won its single largest order of ₹133.98 crore (excl. GST) for 38 wind towers executable by Q4 FY27. Total annual manufacturing capacity reached ~612 towers after its Kutch plant became operational in March 2026. The company is actively shifting its mix from pure conversion towards integrated supply, which yields higher absolute EBITDA per tower (₹40–50 lakhs vs ₹25–30 lakhs) despite lower percentage margins.
Confidence: HIGH
What changedAnawil disclosed comprehensive operational metrics, capacity expansion to 612 towers, and order book economics from its analyst conference.
Why it mattersThe transition to 'Integrated Supply' significantly boosts realization per tower to ₹3.0–3.5 crore and absolute EBITDA to ₹40–50 lakhs, driving higher earnings power as capacity utilisation scales from 48.2%.
Order book as of March 31, 2026: ~Rs 359.82 CrSubsequent single largest order: Rs 133.98 CrTotal annual manufacturing capacity: ~612 towersFY26 capacity utilisation: ~48.2%FY26 production: 210 towers
📅 Short termAs the company enters H2 (which historically delivers ~70% of revenue), execution velocity and quarterly tower dispatches are expected to ramp up.
📈 Long termScaling capacity to 612 towers and increasing in-house manufacturing of internals at Koppal structurally positions the company to capture growing domestic wind installations with higher EBITDA per tower.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Customer concentration risk with the order book spread across just six customers
- Certification delays or slow client approvals for the newly commissioned Kutch facility
- Pronounced seasonality with H1 exposed to monsoon disruptions in logistics and installations
Key Highlights
Order book stood at ~₹359.82 crore (379 towers) as of March 31, 2026, plus a subsequent win of ₹133.98 crore (38 towers)
Total annual manufacturing capacity expanded to ~612 towers following the March 2026 commissioning of the Kutch facility
Production grew from 135 towers in FY25 to 210 towers in FY26 (48.2% capacity utilisation), increasing EBITDA per tower from ~₹22 lakh to ₹29 lakh
Business exhibits strong seasonality, with ~70% of FY26 revenue generated in H2 (October to March)
👀 What to Watch
Track capacity ramp-up and client certifications at the newly commissioned Kutch facility, alongside the execution schedule of the ₹133.98 crore order through Q4 FY27.
Rollatainers Shareholders Approve Acquisition of Related Party Satelite Forging at 55th AGM
Rollatainers Limited announced the results of its 55th AGM held on September 30, 2026, where shareholders passed all 4 resolutions. Notably, a special resolution approving the acquisition of shares in related party Satelite Forging Private Limited was passed with 99.17% favorable votes among voting non-promoters (193,318 votes in favor, with promoters abstaining). Additionally, resolutions adopting FY26 financial statements, re-appointing director Aarti Jain, and approving FY27 related party transactions were approved with near 100% majority. The acquisition marks a significant corporate step for a company reporting zero TTM revenue following the sale of its key operating subsidiary.
Confidence: HIGH
What changedShareholders formally approved the acquisition of shares in related entity Satelite Forging Private Limited along with standard AGM ordinary business items.
Why it mattersRollatainers has had zero operational revenue post the sale of RT Packaging Limited; acquiring a related party business may bring new operating assets, though related-party valuations pose governance risks.
AGM Date: September 30, 2026Satelite Forging votes in favor: 193,318Satelite Forging approval %: 99.1730%Total promoter shares: 127,460,400
📅 Short termMarket attention will focus on disclosures regarding the purchase price, funding structure, and timeline for the Satelite Forging transaction.
📈 Long termThe structural direction hinges on whether Satelite Forging provides viable operating cash flows to replace the divested packaging business, against an accumulated loss base of over ₹123 Cr.
⚠ Risk flags
- Related-party transaction without valuation or consideration size disclosed in the voting results
- Material uncertainty as a going concern with zero quarterly revenue
Key Highlights
Special resolution passed approving acquisition of shares of Satelite Forging Private Limited, a related party.
Related party acquisition resolution approved with 99.17% votes in favor (193,318 votes) among public non-institutional voters.
Promoters abstained/had zero valid votes cast on the related party acquisition resolution (127,460,400 shares held).
Adoption of FY26 audited accounts and FY27 related party transactions approved with 99.998% majority (133,960,789 votes in favor).
👀 What to Watch
Track subsequent exchange filings detailing the acquisition consideration, transaction valuation, and business profile of Satelite Forging Private Limited.
ACME Solar Commissions Additional 66.68 MW Solar Capacity in Rajasthan Under NTPC PPA
ACME Solar Holdings announced that its subsidiary, ACME Renewtech Private Limited, commissioned an additional 66.68 MW of solar capacity in Bikaner, Rajasthan, on October 05, 2026. The Commercial Operation Date (COD) is slated for October 07, 2026. This brings total commissioned capacity for this project to 133.36 MW out of a planned 300 MW Hybrid Power Project. The power generated is tied to a long-term Power Purchase Agreement (PPA) with central offtaker NTPC Limited.
Confidence: HIGH
What changedACME Solar expanded its operational solar asset base by 66.68 MW, moving cumulative capacity at its Bikaner hybrid plant to 133.36 MW.
Why it mattersIncremental operational capacity starts contributing to revenue under the long-term NTPC PPA, supporting the company's target to execute its 7.39 GW pipeline with central offtakers.
Newly commissioned capacity: 66.68 MWTotal project commissioned capacity: 133.36 MWTotal project target capacity: 300 MWCOD date: October 07, 2026
📅 Short termPositive operational milestone; generation revenue will reflect incrementally starting from Q3 FY27 following the COD on October 07, 2026.
📈 Long termStrengthens ACME Solar's steady operational cash flows backed by central counterparty NTPC, aiding in the progressive delivery of its 7.39 GW development pipeline.
⚠ Risk flags
- Weather-related variations impacting plant load factor (PLF)
- Execution and grid connectivity risks for the remaining 166.64 MW balance capacity
Key Highlights
Commissioned additional 66.68 MW solar capacity on October 05, 2026
Commercial Operation Date (COD) scheduled for October 07, 2026
Total commissioned capacity reaches 133.36 MW out of 300 MW hybrid project
PPA executed with central offtaker NTPC Limited
👀 What to Watch
Monitor the project's ramp-up to commercial generation from October 07, 2026, and track execution timelines for the remaining ~166.64 MW of this 300 MW hybrid project.
Marico acquires additional 24.09% in Plix owner for ₹1,012.03 Cr, stake rises to 84.09%
Marico has entered into definitive agreements to acquire a 38.18% stake in tranches in Satiya Nutraceuticals (owner of 'Plix'), scaling its current stake from 60% to 84.09%. Marico paid an all-cash consideration of ₹1,012.03 Crores for this 24.09% tranche, taking aggregate investment to date to ₹1,392.07 Crores. The target has demonstrated rapid scaling, with consolidated turnover rising from ₹155.32 Crores in FY24 to ₹864.31 Crores in FY26. The final 14.09% stake is slated for acquisition in July 2027 at a base consideration of up to ₹592 Crores plus milestone-linked payouts.
Confidence: HIGH
What changedMarico increased its controlling stake in subsidiary Satiya Nutraceuticals (brand 'Plix') from 60% to 84.09% through an immediate cash buyout.
Why it mattersPlix is an engine in Marico's digital-first and nutrition portfolio, delivering ₹864.31 Cr turnover (~6.3% of Marico's TTM revenue); full consolidation strengthens long-term growth and capital allocation.
Tranche consideration: ₹ 1,012.03 CroresTranche stake acquired: 24.09%Current aggregate stake: 84.09%Plix FY26 turnover: ₹ 864.31 CroresPlix FY26 turnover vs Marico TTM revenue: ~6.35%Tranche cost vs Net worth: ~17.4%
📅 Short termSubstantial cash outlay of ₹1,012.03 Cr will reduce Marico's surplus cash reserves, but reinforces ownership in a fast-growing, high-momentum subsidiary.
📈 Long termExpands Marico's addressable market in plant-based nutrition and premium wellness, accelerating its strategic shift towards high-growth digital-first brands.
⚠ Risk flags
- Valuation sensitivity linked to milestone-based earnouts
- Sustaining growth and profitability as Plix scales
Key Highlights
Acquired 24.09% stake for ₹1,012.03 Crores in cash, increasing holding from 60% to 84.09%
Total consideration paid for 84.09% stake stands at ₹1,392.07 Crores
Agreement in place to acquire remaining 14.09% in July 2027 for a base consideration of up to ₹592 Crores plus earnouts
Plix consolidated turnover jumped ~100% YoY to ₹864.31 Crores in FY26 from ₹432.84 Crores in FY25 (and ₹155.32 Cr in FY24)
👀 What to Watch
Track the integration and margin profile of Plix in upcoming quarterly disclosures, along with cash balance utilization following the ₹1,012 Cr cash outflow.
IndusInd Bank Q2 FY27 Advances Rise 11.2% YoY to ₹3,62,393 Cr; CASA Drops to 28.0%
IndusInd Bank reported its provisional business figures for the quarter ended September 30, 2026, showing net advances of ₹3,62,393 crore, up 11.2% YoY and 11.1% QoQ. Total deposits grew 10.1% YoY to ₹4,29,038 crore, while retail and small business deposits reached ₹2,14,504 crore. However, the CASA ratio weakened sequentially and annually to 28.0%, down from 29.4% in June 2026 and 30.7% in September 2025. Additionally, the bank mobilized USD 3.51 billion (~₹33,627 crore) in FCNR(B) deposits under the RBI swap facility.
Confidence: HIGH
What changedIndusInd Bank published its preliminary quarterly loan and deposit metrics ahead of full Q2 financial results.
Why it mattersDemonstrates sustained double-digit loan and deposit growth, though a declining CASA mix signals higher funding costs which could pressure net interest margins.
Net Advances: ₹3,62,393 croreTotal Deposits: ₹4,29,038 croreCASA Ratio: 28.0%FCNR (B) Deposits Mobilised: USD 3.51 billion (~ ₹33,627 crore)
📅 Short termSets baseline expectations for Q2 results, with the strong loan pickup balanced by the drop in low-cost CASA deposits.
📈 Long termSustained deposit mobilization and diversification remain central to managing the Credit-to-Deposit ratio and balancing cost of funds.
⚠ Risk flags
- Continued deterioration in the CASA ratio to 28.0%, potentially raising overall cost of funds.
Key Highlights
Net advances increased 11.2% YoY and 11.1% QoQ to ₹3,62,393 crore as of September 30, 2026.
Total deposits grew 10.1% YoY and 3.4% QoQ to ₹4,29,038 crore.
CASA ratio contracted to 28.0%, compared to 29.4% in the previous quarter and 30.7% a year ago.
Mobilised USD 3.51 billion (~₹33,627 crore) in FCNR(B) deposits under RBI swap scheme, with GIFT City loans of USD 1.73 billion (~₹16,564 crore) extended against them.
👀 What to Watch
Track full Q2 FY27 audited earnings for net interest margin impact stemming from the lower CASA ratio and overall credit cost trends.
Dhariwalcorp Proposes ₹8.63 Cr Preferential Issue of 33 Lakh Shares to Promoter
Dhariwalcorp Limited has issued a notice convening an Extraordinary General Meeting (EGM) on October 29, 2026, to seek shareholder approval for a preferential issue. The company plans to issue up to 33,00,000 equity shares of face value ₹2 each at ₹26.14 per share (including a premium of ₹24.14) to promoter Shakshi Dhariwal. The proposed fundraise totals up to ₹8.63 Cr, which represents approximately 13.9% of the company's net worth of ₹62 Cr. The relevant date for pricing determination was set as September 29, 2026.
Confidence: HIGH
What changedDhariwalcorp has initiated an EGM notice to approve the issuance of 33 lakh equity shares to a promoter, raising ₹8.63 Cr via preferential allotment.
Why it mattersThe ₹8.63 Cr capital injection strengthens the company's equity base by ~13.9% of its net worth (₹62 Cr), infusing fresh promoter capital to support business operations.
Total issue amount: Rs. 8,62,62,000Number of shares: 33,00,000Issue price per share: Rs. 26.14Issue vs Net Worth: ~13.9%EGM date: October 29, 2026
📅 Short termFocus will remain on shareholder approval at the October 29 EGM and subsequent receipt of stock exchange listing approvals.
📈 Long termProvides incremental growth capital and signals promoter financial commitment, though operational margin expansion remains key for earnings growth.
⚠ Risk flags
- Equity dilution for existing public shareholders
- Concentration of issue entirely within the promoter group
Key Highlights
Preferential issuance of up to 33,00,000 equity shares of face value ₹2 each
Issue price fixed at ₹26.14 per share, including a premium of ₹24.14 per share
Total fundraising amount aggregates up to ₹8,62,62,000 (₹8.63 Cr)
Entire proposed allotment is targeted to promoter Shakshi Dhariwal
EGM scheduled for Thursday, October 29, 2026, with the pricing relevant date on September 29, 2026
👀 What to Watch
Track shareholder voting results from the EGM on October 29, 2026, followed by in-principle approval and listing confirmation from the NSE.
Rajgor Castor Secures Trading Approval for 2.39 Cr Rights Equity Shares
Rajgor Castor Derivatives Limited has received trading approval from the National Stock Exchange of India (NSE) for 2,39,13,000 equity shares issued via a rights issue. The shares of face value Rs. 10 each were allotted on September 30, 2026, and listed on October 1, 2026. Trading in these newly issued shares will commence on October 06, 2026, under the SM series. This represents a substantial equity base expansion for the company.
Confidence: HIGH
What changedNSE granted final trading approval for 2.39 crore rights equity shares, making them eligible for secondary market trading starting October 6, 2026.
Why it mattersThe listing and trading clearance completes the rights issuance process, expanding the circulating share base and liquidity while formalizing equity capital dilution.
Shares approved for trading: 23913000Face value per share: Rs. 10/-Trading commencement date: October 06, 2026Allotment date: September 30, 2026
📅 Short termMay introduce short-term selling pressure or increased liquidity in the stock starting October 06, 2026, as newly allotted rights shares become tradable.
📈 Long termLimited operational impact from the procedural listing approval itself, though capital raised alters per-share financial metrics and leverage ratios.
⚠ Risk flags
- Equity dilution from significant share base expansion
- Potential near-term supply overhang as newly allotted shares hit the market
Key Highlights
Trading approval received for 2,39,13,000 equity shares of Rs. 10 each issued on a rights basis
Trading of the new shares to commence on NSE from October 06, 2026
Shares were allotted on September 30, 2026, following NSE in-principle approval on August 07, 2026
Distinctive numbers assigned span from 23915853 to 47828852 under symbol RCDL
👀 What to Watch
Track the deployment of rights issue proceeds and monitor the impact of equity dilution on future reported earnings per share (EPS).
SAB Events Clears All Dues Under NCLT-Approved Resolution Plan
SAB Events & Governance Now Media has fulfilled all payment obligations toward unpaid PPIRP costs, financial creditors, and operational creditors within the timelines approved by the NCLT. This follows the Hon'ble NCLT Order dated July 10, 2026, approving the resolution plan under Sections 54K(12), 54L, and 31 of the IBC. The payments were conducted under the oversight of the Monitoring Committee, marking the successful implementation of its resolution plan. Specific settlement payout amounts were not disclosed in the filing.
Confidence: HIGH
What changedThe company has fully executed its payment obligations to financial and operational creditors under the NCLT-approved Pre-Packaged Insolvency Resolution Process (PPIRP).
Why it mattersSuccessful completion of these payments lifts insolvency-related overhangs and clears outstanding liabilities, providing operational stability to the distressed media business.
NCLT approval date: July 10, 2026Filing date: October 05, 2026Total settlement amount: not disclosed
📅 Short termRemoves immediate insolvency risk, allowing management to refocus resources toward normal business operations and digital content monetization.
📈 Long termCleans the company's balance sheet, though sustainable long-term revival depends on reversing operational net losses and scaling up the core TTM revenue base of Rs 2 Cr.
⚠ Risk flags
- Negative net worth (Rs -2 Cr) and persistent quarterly operating losses
- Lack of disclosure regarding exact haircut or cash outflow amounts paid to creditors
Key Highlights
Full clearance of all unpaid PPIRP costs, financial creditors, and operational creditors completed
Payments executed per timelines stipulated in the NCLT Order dated July 10, 2026
Resolution executed under IBC Sections 54K(12) and 54L read with Section 31
Total payout amounts for creditor settlements were not disclosed in the filing
👀 What to Watch
Track subsequent filings for the formal conclusion/dissolution of the Monitoring Committee and review upcoming quarterly financials to observe post-resolution debt levels and balance sheet health.
Open Offer for 26% Stake at Rs 72/Share Triggers Change in Control for Hiliks Technologies
Enact Technologies Pvt Ltd along with two individuals and three PACs have announced an open offer to acquire up to 36,92,000 equity shares (26.00% of expanded share capital) of Hiliks Technologies at Rs 72 per share, totaling Rs 26.58 Cr. The offer is triggered by a Share Purchase Agreement to acquire 5,00,000 shares (3.52%) from promoter Extros Developers Pvt Ltd for Rs 3.60 Cr, accompanied by a transfer of control. The open offer price of Rs 72 represents an 18% premium over the current market price of Rs 61. Post-SPA and warrant conversion, the acquirers' holding would reach 25.59% prior to the open offer.
Confidence: HIGH
What changedAcquirers entered into an SPA to buy 3.52% from the promoter and assume control, triggering a mandatory open offer for 26% of expanded equity.
Why it mattersThe incoming promoter group acquires complete management control at an offer valuation of Rs 72/share (total offer size of Rs 26.58 Cr vs company net worth of Rs 27 Cr), potentially altering the business trajectory.
Offer Price: Rs. 72/-Offer Size (Shares): 36,92,000Offer Size (Value): Rs. 26,58,24,000/-Expanded Share Capital: 1,42,00,000 sharesOffer value vs Market Cap: ~40.9%
📅 Short termThe stock price is likely to track toward the open offer price of Rs 72 in the near term as market participants price in the open offer arbitrage.
📈 Long termA change of management and control could reshape strategic direction, governance, and business volume for this micro-cap investment entity.
⚠ Risk flags
- Regulatory approval delays from SEBI or stock exchanges
- Low historical promoter holding and thin operating history
Key Highlights
Open offer price set at Rs 72 per share, an 18% premium to current market price of Rs 61.0
Open offer for up to 36,92,000 equity shares (26.00% of expanded voting capital) valued at Rs 26.58 Cr
Underlying SPA to acquire 5,00,000 shares (3.52%) for Rs 3.60 Cr, triggering management change of control
Detailed Public Statement (DPS) scheduled to be published on or before October 12, 2026
👀 What to Watch
Track the publication of the Detailed Public Statement by October 12, 2026, and subsequent Letter of Offer for the schedule of tendering and SEBI approval timelines.
SRM Contractors AGM Approves Borrowing Limit Hike to ₹2,000 Cr, QIP, and Warrant Issuance
SRM Contractors announced that all 16 resolutions at its 18th Annual General Meeting held on September 30, 2026, were approved with requisite majority. Key approvals include raising the company's borrowing limit from ₹1,000 crore to ₹2,000 crore, enabling future funding for large infrastructure projects. Shareholders also approved raising funds via a Qualified Institutional Placement (QIP) and issuing up to 19,34,236 convertible warrants to promoter entities. Additionally, multiple material related-party transactions were cleared, including with subsidiary Maccaferri Infrastructure Private Limited.
Confidence: HIGH
What changedShareholders formally approved enabling resolutions to raise the borrowing ceiling to ₹2,000 crore, launch a QIP, and issue promoter warrants.
Why it mattersThe doubled borrowing limit and capital-raise approvals provide headroom to finance order book expansion and the Maccaferri Infrastructure acquisition without immediate leverage constraints.
Borrowing limit increase: from 1000 crores to 2000 croresPromoter warrants approved: up to 19,34,236Total voting shares: 22944200Borrowing headroom vs TTM revenue: ~185%
📅 Short termNeutral to mildly positive. The approvals are standard enabling provisions; share reaction will depend on concrete dilution details when the QIP and warrant pricing are finalized.
📈 Long termExpands balance sheet capacity significantly to support execution of complex tunneling and hybrid annuity model (HAM) projects across northern and eastern India.
⚠ Risk flags
- Equity dilution from the proposed QIP and issuance of 1.93 million convertible warrants
- Increased leverage risk if borrowings approach the expanded ₹2,000 crore cap
- Substantial related-party transactions with JVs and subsidiary entities
Key Highlights
Shareholders approved doubling the borrowing limit from ₹1,000 crore to ₹2,000 crore under Section 180(1)(c)
Approved issuance of up to 19,34,236 fully convertible warrants to Promoter & Promoter Group entities on a preferential basis
Special resolution passed to raise funds through Qualified Institutional Placement (QIP)
Material related-party transactions approved with Maccaferri Infrastructure and four Joint Venture projects
Overall voter turnout saw 15.89 million votes cast out of 22.94 million shares, passing key resolutions with over 99.9% approval
👀 What to Watch
Track subsequent board announcements regarding the pricing, timing, and size of the planned QIP, as well as the terms and dilution impact of the 1.93 million promoter warrants.
